SE0002820D0 - Medical kit - Google Patents

Medical kit

Info

Publication number
SE0002820D0
SE0002820D0 SE0002820A SE0002820A SE0002820D0 SE 0002820 D0 SE0002820 D0 SE 0002820D0 SE 0002820 A SE0002820 A SE 0002820A SE 0002820 A SE0002820 A SE 0002820A SE 0002820 D0 SE0002820 D0 SE 0002820D0
Authority
SE
Sweden
Prior art keywords
medical kit
drug
biological fluid
labelled
labelled anti
Prior art date
Application number
SE0002820A
Other languages
English (en)
Other versions
SE0002820L (sv
Inventor
Ahmed Jehanli
Adnan Badwan
Mohammed Saleem
Original Assignee
Jordanian Pharmaceutical Mfg &
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jordanian Pharmaceutical Mfg & filed Critical Jordanian Pharmaceutical Mfg &
Priority to SE0002820A priority Critical patent/SE0002820L/sv
Publication of SE0002820D0 publication Critical patent/SE0002820D0/sv
Priority to JP2001228330A priority patent/JP2002296278A/ja
Priority to US09/918,637 priority patent/US20020025538A1/en
Priority to DK01850136T priority patent/DK1178316T3/da
Priority to DE60108316T priority patent/DE60108316T2/de
Priority to AT01850136T priority patent/ATE287083T1/de
Priority to EP01850136A priority patent/EP1178316B1/en
Priority to ES01850136T priority patent/ES2231426T3/es
Publication of SE0002820L publication Critical patent/SE0002820L/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/942—Serotonin, i.e. 5-hydroxy-tryptamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SE0002820A 2000-08-04 2000-08-04 Medicinskt kit SE0002820L (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE0002820A SE0002820L (sv) 2000-08-04 2000-08-04 Medicinskt kit
JP2001228330A JP2002296278A (ja) 2000-08-04 2001-07-27 医療用キット
US09/918,637 US20020025538A1 (en) 2000-08-04 2001-08-01 Medical kit
DK01850136T DK1178316T3 (da) 2000-08-04 2001-08-03 Medicinsk kit og fremgangsmåde til bestemmelse af et lægemiddel
DE60108316T DE60108316T2 (de) 2000-08-04 2001-08-03 Medizinische Kit und Methode zur Bestimmung eines Arzneimittels
AT01850136T ATE287083T1 (de) 2000-08-04 2001-08-03 Medizinische kit und methode zur bestimmung eines arzneimittels
EP01850136A EP1178316B1 (en) 2000-08-04 2001-08-03 Medical Kit and method for the determination of a drug
ES01850136T ES2231426T3 (es) 2000-08-04 2001-08-03 Kit de uso medico y metodo para la determinacion de un farmaco.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0002820A SE0002820L (sv) 2000-08-04 2000-08-04 Medicinskt kit

Publications (2)

Publication Number Publication Date
SE0002820D0 true SE0002820D0 (sv) 2000-08-04
SE0002820L SE0002820L (sv) 2002-02-05

Family

ID=20280626

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0002820A SE0002820L (sv) 2000-08-04 2000-08-04 Medicinskt kit

Country Status (8)

Country Link
US (1) US20020025538A1 (sv)
EP (1) EP1178316B1 (sv)
JP (1) JP2002296278A (sv)
AT (1) ATE287083T1 (sv)
DE (1) DE60108316T2 (sv)
DK (1) DK1178316T3 (sv)
ES (1) ES2231426T3 (sv)
SE (1) SE0002820L (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040168951A1 (en) * 2003-02-27 2004-09-02 Mackie Robert W. Method and system for self administration of medications
WO2005111616A1 (ja) * 2004-05-14 2005-11-24 Toray Industries, Inc. 標的物質を迅速簡便に検出する方法およびそのための酵素免疫学的キット
GB2404022B (en) 2004-06-14 2005-08-10 Cozart Bioscience Ltd Competitive assays for the detection of methamphetamine group drugs
GB2404023B (en) 2004-07-02 2005-07-06 Cozart Bioscience Ltd Delta-9-tetrahydrocannabinol detection method
CN103389377A (zh) * 2012-05-08 2013-11-13 上海大学 液相芯片检测水产品中氯霉素的方法
CN103389378A (zh) * 2012-05-08 2013-11-13 上海大学 检测水产品中氯霉素残留的试剂盒
CN105319353A (zh) * 2014-07-23 2016-02-10 江苏维赛科技生物发展有限公司 一种检测二氢吡啶类药物残留的酶联免疫试剂盒的制备
CN105353095B (zh) * 2015-11-16 2017-10-20 华南农业大学 一种西地那非及其结构类似物的免疫检测方法
US10660619B2 (en) 2017-07-19 2020-05-26 Evanostics Llc Cartridges for oral fluid analysis and methods of use
WO2019118989A1 (en) 2017-12-15 2019-06-20 Evanostics Llc Optical reader for analyte testing
WO2020045524A1 (ja) * 2018-08-29 2020-03-05 富士フイルム株式会社 クロマトグラフキットおよびクロマトグラフ方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584129A (en) * 1977-06-10 1981-02-04 Nayak P Method and apparatus for performing in vitro clinical diagnostic tests using a solid phase assay system
US4606855A (en) * 1982-07-26 1986-08-19 Mex Research Associates C/O Leon Reimer Monoclonal antibody to digoxin
US4477576A (en) * 1982-07-26 1984-10-16 Mex Research Associates Antigen assay method and kit
FR2598514B1 (fr) * 1986-05-12 1988-07-01 Commissariat Energie Atomique Procede de dosage immunologique des hormones thyroidiennes t3 et/ou t4 utilisant la thyroglobuline
ES2092523T3 (es) * 1990-05-09 1996-12-01 Abbott Lab Ensayos que utilizan enlaces con recuperacion de conjugado.
US5238652A (en) * 1990-06-20 1993-08-24 Drug Screening Systems, Inc. Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques
DE19722815A1 (de) * 1997-05-30 1998-12-03 Cell Diagnostica Gmbh Ges Fuer Verfahren zum quantifizierenden und differenzierenden Nachweis verschiedener Biomoleküle an fester Phase in einem einzigen Testansatz

Also Published As

Publication number Publication date
SE0002820L (sv) 2002-02-05
US20020025538A1 (en) 2002-02-28
EP1178316B1 (en) 2005-01-12
EP1178316A1 (en) 2002-02-06
JP2002296278A (ja) 2002-10-09
ATE287083T1 (de) 2005-01-15
ES2231426T3 (es) 2005-05-16
DE60108316T2 (de) 2005-06-02
DE60108316D1 (de) 2005-02-17
DK1178316T3 (da) 2005-03-07

Similar Documents

Publication Publication Date Title
WO2002010754A3 (en) Assay apparatus
SE0002820L (sv) Medicinskt kit
CY1107537T1 (el) Ανaλυση συνδυασμoy hcv αντιγoνου/αντισωματος
EE200300128A (et) Meetod allergeeniga seostuva immunoglobuliini detekteerimiseks proovis, patsiendi allergiate in vitro diagnoosimeetod, mikromaatrikskiip ja komplekt
DE69623458T2 (de) Einstufige immunochromatographische vorrichtung und verfahren zu ihrer verwendung
EP0375422A3 (en) Composition and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
EP1092979A3 (en) Devices made by covalent bonding of molecules to an activated solid phase
EP1086372A1 (en) Collection device for single step assay of oral fluids
ATE464374T1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
ES2119369T3 (es) Dispositivo sensor para un ensayo sandwich.
US20180313829A1 (en) Progressive compression driven flow cartridge for analyte detecting strip and method
WO2002090961A3 (en) Systems and methods for detection of analytes in biological fluids
DK1167389T3 (da) Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
EP1424558A4 (en) REAGENT FOR TESTING LAMININE-5-ANTIGENS IN A BIOLOGICAL SAMPLE AND TEST PROCEDURE
ATE254286T1 (de) Zwei-inkubations mit markiertem antigen verwendenes immunoassay
CA2349274A1 (en) Assay for anti transglutaminase antibodies
MY106963A (en) Agglutination assay.
EP0878551A3 (de) Erhöhung der FVII Empfindlichkeit eines Thromboplastinreagenzes
PT672756E (pt) Anticorpo monoclonal que reconhece a proteina de ligacao a fk506 processo de doseamento do nivel de proteina de ligaca a fk506 e "kit" para doseamento
DE69523492D1 (de) Immunoassay-Reagenzien, Testsätze und Verfahren
ATE434185T1 (de) Immunoassay für h. pylori in fäkalienproben mit hilfe von gattungsspezifischen antikörpern
DE69533904D1 (de) Chemische Modifikation von Antikörpern und Antigenen
ATE285075T1 (de) Detektion und quantifikation von vancomycin in den biologischen flüssigkeiten
DE60124846D1 (de) Mehranalyte-Immunoassay

Legal Events

Date Code Title Description
NAV Patent application has lapsed